Marcelo Bigal

Person

Doylestown, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treating refractory migraine
- Patent number 12,139,528
- Issue date Nov 12, 2024
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treating headache comprising administering an antibody to calcitoni...
- Patent number 11,555,064
- Issue date Jan 17, 2023
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating refractory migraine
- Patent number 11,028,160
- Issue date Jun 8, 2021
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating refractory migraine
- Patent number 11,028,161
- Issue date Jun 8, 2021
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonist antibodies directed against calcitonin gene-related pept...
- Patent number 10,556,945
- Issue date Feb 11, 2020
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treating headache comprising administering an antibody to calcitoni...
- Patent number 10,519,224
- Issue date Dec 31, 2019
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treating refractory migraine
- Patent number 10,392,434
- Issue date Aug 27, 2019
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonist antibodies directed against calcitonin gene-related pept...
- Patent number 9,896,502
- Issue date Feb 20, 2018
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATING REFRACTORY MIGRAINE
- Publication number 20230242631
- Publication date Aug 3, 2023
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...
- Publication number 20230235032
- Publication date Jul 27, 2023
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING REFRACTORY MIGRAINE
- Publication number 20220098287
- Publication date Mar 31, 2022
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEAD...
- Publication number 20220048986
- Publication date Feb 17, 2022
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATING REFRACTORY MIGRAINE
- Publication number 20210040191
- Publication date Feb 11, 2021
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING REFRACTORY MIGRAINE
- Publication number 20210040190
- Publication date Feb 11, 2021
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...
- Publication number 20200377581
- Publication date Dec 3, 2020
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...
- Publication number 20200331991
- Publication date Oct 22, 2020
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING REFRACTORY MIGRAINE
- Publication number 20200223911
- Publication date Jul 16, 2020
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEAD...
- Publication number 20200148761
- Publication date May 14, 2020
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATING CLUSTER HEADACHE
- Publication number 20200102377
- Publication date Apr 2, 2020
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...
- Publication number 20190031745
- Publication date Jan 31, 2019
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING REFRACTORY MIGRAINE
- Publication number 20180127490
- Publication date May 10, 2018
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING CLUSTER HEADACHE
- Publication number 20180111984
- Publication date Apr 26, 2018
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEAD...
- Publication number 20170088612
- Publication date Mar 30, 2017
- Teva Pharmaceuticals International GmbH
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPT...
- Publication number 20150322142
- Publication date Nov 12, 2015
- Labrys Biologics, Inc.
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPT...
- Publication number 20150266948
- Publication date Sep 24, 2015
- Labrys Biologics, Inc.
- Marcelo Bigal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Marcelo Bigal

Person

Patents Grantslast 30 patents

Treating refractory migraine

Treating headache comprising administering an antibody to calcitoni...

Treating refractory migraine

Treating refractory migraine

Antagonist antibodies directed against calcitonin gene-related pept...

Treating headache comprising administering an antibody to calcitoni...

Treating refractory migraine

Antagonist antibodies directed against calcitonin gene-related pept...

Patents Applicationslast 30 patents

TREATING REFRACTORY MIGRAINE

Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...

TREATING REFRACTORY MIGRAINE

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEAD...

TREATING REFRACTORY MIGRAINE

TREATING REFRACTORY MIGRAINE

Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...

Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...

TREATING REFRACTORY MIGRAINE

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEAD...

TREATING CLUSTER HEADACHE

Antagonist Antibodies Directed Against Calcitonin Gene-Related Pept...

TREATING REFRACTORY MIGRAINE

TREATING CLUSTER HEADACHE

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEAD...

ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPT...

ANTAGONIST ANTIBODIES DIRECTED AGAINST CALCITONIN GENE-RELATED PEPT...